Less is more for LSD sufferers on Rare Disease Day

What would you do if your child were struck by a strange illness and began to wilt before your eyes. An illness that few doctors understood, even fewer could treat, that most likely did not have a cure, and even if it did,  you couldn't afford it? Faced by a parent's worse nightmare come true … Continue reading Less is more for LSD sufferers on Rare Disease Day

Advertisement

Sanofi’s play for Genzyme – stray thoughts

The last couple of days has seen some speculation about sanofi aventis' play for Genzyme.  Big Pharma's acquisitiveness for biotech's not new - this is just the latest example. In the last decade (maybe a little more), biotech seems to have been having better luck than Big Pharma putting new drugs into the pipeline especially … Continue reading Sanofi’s play for Genzyme – stray thoughts